Skip to main content
. Author manuscript; available in PMC: 2019 Oct 9.
Published in final edited form as: Sex Transm Dis. 2005 Mar;32(3):194–198. doi: 10.1097/01.olq.0000154494.95138.70

TABLE 1.

Positivity Rates and Treatment Outcomes Among Women With Chlamydial and Gonococcal Infections Seen at STD Clinics in 3 US Cities, 2002

Washington, DC (1 of 1 clinic) Los Angeles (3 of 13 clinics) San Diego (main clinic)
Chlamydia trachomatis
 Positive/tested (%) 149/2607 (5.7)* 522/3764 (13.9) 131/2203 (5.9)
 % Infected women presumptively treated 91% 79% 69%
 Infected women requiring follow-up treatment, per month 1.1 9.3 3.4
Neisseria gonorrhoeae
 Positive/tested (%) 151/2609 (5.8)* 129/3917 (3.3) 27/2043 (1.3)
 % Infected women presumptively treated 93% 58% 63%
 Infected women requiring follow-up treatment per months 0.8 4.5 0.8
*

Testing performed with DNA probe test.

Testing performed with nucleic acid amplification test.

Women coinfected with C trachomatis and N gonorrhoeae were included in both study groups.